4D pharma plc filed its 20-F on Mar 31, 2022 for the period ending Dec 31, 2021. In this report its auditor, McGladrey LLP - RSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+9.04% | 114B | |
+11.37% | 104B | |
-12.36% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.53% | 17.89B | |
+8.15% | 14.28B | |
+35.09% | 12.55B |